Followers | 127 |
Posts | 8266 |
Boards Moderated | 2 |
Alias Born | 02/20/2006 |
Tuesday, November 03, 2020 3:16:46 AM
Trial — the Israel government is in talks with $BVXV to use their fancy facility to manufacture COVID vaccines. Expect official PR soon.
insert-text-here
Here is the website.its not on English but I generously translated it for you.
Will the vaccine be produced in Israel?
Whether the vaccine is marketed to a large pharmaceutical company or
Remains fully under the responsibility and ownership of the Biological institute, it is likely that a manufacturing site will be opened in Israel that will serve the Israeli public. This is a reasonable condition to require under any potential commercialization agreement with a foreign company.
There are several plants in Israel that can be converted to produce a vaccine for Corona: the BiondVax plant, which recently failed to develop
A perennial flu vaccine, and the Muffi plant in Jerusalem, which is awaiting approval to produce a generic version of Copaxone with a delayed release, but its manager Enid Marom for a vaccine plant, at least temporarily.
Beyond that, VBI owns a vaccine manufacturing plant in Rehovot, and the
Yeruham Council has began preparations to establish a new vaccine plant on its territory, where Corona vaccines can also be produced..
Bvxv’s facility was built with grants received from the Israeli government. Hope to be of helpful.
Cheers!
Recent BVXV News
- Form NT 20-F - Notification of inability to timely file Form 20-F • Edgar (US Regulatory) • 04/30/2024 08:06:46 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/16/2024 09:27:06 PM
- Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG • PR Newswire (US) • 04/10/2024 11:00:00 AM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 03/12/2024 08:17:13 PM
- Scinai leadership to attend BIO-Europe Spring 2024 • PR Newswire (US) • 03/12/2024 12:00:00 PM
- Scinai Welcomes Liat Halpert as Head of Business Development and Sales • PR Newswire (US) • 02/13/2024 12:00:00 PM
- Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds • PR Newswire (US) • 01/04/2024 09:01:00 PM
- Scinai Immunotherapeutics Regains Compliance with Nasdaq's Stockholders' Equity Rule • PR Newswire (US) • 11/20/2023 12:30:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM